Abstract |
An abnormal high mobility group box 1 ( HMGB1) activation and a decrease in receptor for advanced glycation end-product (RAGE) play a key role in the pathogenesis of pulmonary fibrosis. Protocatechuic aldehyde (PA) is a naturally occurring compound, which is extracted from the degradation of phenolic acids. However, whether PA has anti-fibrotic functions is unknown. In this study, the effects of PA on the transforming growth factor-β1 (TGF-β1)-mediated epithelial-mesenchymal transition (EMT) in A549 cells, on the apoptosis of human type I alveolar epithelial cells (AT I), on the proliferation of human lung fibroblasts (HLF-1) in vitro, and on bleomycin (BLM)-induced pulmonary fibrosis in vivo were investigated. PA treatment resulted in a reduction of EMT in A549 cells with a decrease in vimentin and HMGB, an increase of E-cadherin and RAGE, a reduction of HLF-1 proliferation with a decrease of fibroblast growth factor 2 (FGF-2) and platelet-derived growth factor (PDGF). Apoptosis of AT I was attenuated with an increase of RAGE. PA ameliorated BLM-induced pulmonary fibrosis in rats with a reduction of histopathological scores and collagen deposition, and a lower FGF-2, PDGF, α-smooth muscle actin (α-SMA) and HMGB1 expression, whereas higher RAGE was found in BLM-instilled lungs. Through the decrease of HGMB1 and the regulation of RAGE, PA reversed the EMT, inhibited HLF-1 proliferation as well as reduced apoptosis in AT I, and prevented pulmonary fibrosis in vivo. Collectively, our results demonstrate that PA prevents experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway.
|
Authors | Liang Zhang, Yunxia Ji, Zechun Kang, Changjun Lv, Wanglin Jiang |
Journal | Toxicology and applied pharmacology
(Toxicol Appl Pharmacol)
Vol. 283
Issue 1
Pg. 50-6
(Feb 15 2015)
ISSN: 1096-0333 [Electronic] United States |
PMID | 25582705
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Actins
- Benzaldehydes
- Catechols
- HMGB1 Protein
- HMGB1 protein, human
- Hbp1 protein, rat
- Platelet-Derived Growth Factor
- RNA, Small Interfering
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic
- Transforming Growth Factor beta1
- smooth muscle actin, rat
- Fibroblast Growth Factor 2
- Bleomycin
- protocatechualdehyde
- Collagen
|
Topics |
- Actins
(metabolism)
- Animals
- Apoptosis
(drug effects)
- Benzaldehydes
(pharmacology, therapeutic use)
- Bleomycin
- Catechols
(pharmacology, therapeutic use)
- Cell Line
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Collagen
(metabolism)
- Epithelial-Mesenchymal Transition
(drug effects)
- Fibroblast Growth Factor 2
(metabolism)
- HMGB1 Protein
(genetics, metabolism)
- Humans
- Lung
(drug effects, metabolism, pathology)
- Male
- Platelet-Derived Growth Factor
(metabolism)
- Pulmonary Fibrosis
(chemically induced, drug therapy, metabolism, pathology)
- RNA, Small Interfering
(genetics)
- Rats, Sprague-Dawley
- Receptor for Advanced Glycation End Products
- Receptors, Immunologic
(metabolism)
- Signal Transduction
- Transforming Growth Factor beta1
(pharmacology)
|